18.82
0.36 (1.95%)
0.36 (1.95%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alkermes Plc | ALKS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.36 | 1.95% | 18.82 | 17:15:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 18.37 | 18.33 | 18.86 | 18.82 | 18.46 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 18.26 | 18.97 | 0.71 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,987 | 763,279 | $ 18.64 | $ 14,223,921 | 1,172,528 | 11.98 - 21.9799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:39 | average | 1,747 | $ 18.82 | USD |
Alkermes Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.00B | 159.15M | 111.83M | $ 1.17B | $ -73.54M | -1.26 | -39.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 2.17k | 1.30% |
Alkermes News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALKS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.36 | 18.86 | 18.07 | 18.39 | 605,717 | 0.46 | 2.51% |
| 1 Month | 16.25 | 19.30 | 16.00 | 17.90 | 1,143,485 | 2.57 | 15.82% |
| 3 Months | 16.40 | 19.68 | 15.35 | 17.23 | 1,207,876 | 2.42 | 14.76% |
| 6 Months | 16.61 | 21.45 | 15.35 | 17.88 | 1,263,005 | 2.21 | 13.31% |
| 1 Year | 20.99 | 21.9799 | 11.98 | 17.58 | 1,470,592 | -2.17 | -10.34% |
| 3 Years | 54.04 | 71.22 | 11.98 | 27.67 | 1,189,617 | -35.22 | -65.17% |
| 5 Years | 72.91 | 80.71 | 11.98 | 35.23 | 1,102,861 | -54.09 | -74.19% |
Alkermes Description
| Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. |
